HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
https://www.blogtalkradio.com/myelomacrowdradio
Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
episode 12: Myeloma Crowd Radio: Ashraf Badros, MD, University of Maryland
Let's talk about multiple myeloma in the African American community
episode 12: Myeloma Crowd Radio: Ashraf Badros, MD, University of Maryland
Let's talk about multiple myeloma in the African American community
episode 13: Myeloma Crowd Radio: Dave Winfield and Don Baylor Jr. on your Most Valuable Plan
How can you become your own best myeloma advocate? It means making a plan.
episode 13: Myeloma Crowd Radio: Dave Winfield and Don Baylor Jr. on your Most Valuable Plan
How can you become your own best myeloma advocate? It means making a plan.
episode 14: Myeloma Crowd: David Chung, MD, PhD, Memorial Sloan Kettering Cancer Center
Can we create an immune system profile for each myeloma patient and how does that signature impact outcomes?
episode 14: Myeloma Crowd: David Chung, MD, PhD, Memorial Sloan Kettering Cancer Center
Can we create an immune system profile for each myeloma patient and how does that signature impact outcomes?
episode 15: Myeloma Crowd Radio: Frank Zhan, PhD and Yogesh Jethava, MD, University of Iowa
Are myeloma stem cells responsible for relapse? Dr. Frank Zhan shares his research on the presence of a potential target called CD24
episode 15: Myeloma Crowd Radio: Frank Zhan, PhD and Yogesh Jethava, MD, University of Iowa
Are myeloma stem cells responsible for relapse? Dr. Frank Zhan shares his research on the presence of a potential target called CD24
episode 16: Myeloma Crowd Radio: Cesar Rodriguez, MD, Wake Forest University
3D Tumor modeling to match each myeloma patient's tumor against today's myeloma therapies
episode 16: Myeloma Crowd Radio: Cesar Rodriguez, MD, Wake Forest University
3D Tumor modeling to match each myeloma patient's tumor against today's myeloma therapies